Thank you, Michael, and good morning, everyone. We remained highly selective with new investments in Q4 as we were effectively at full investment during most of the quarter and successfully achieved our targeted net leverage level of 1.25x while our loan repayment levels were less than typical. During the quarter, we passed on a historically higher percentage of potential investments based on credit and pricing considerations. As Michael discussed in his remarks, market conditions remain very competitive as historic capital inflows continue to chase transactions in a relatively slow M&A environment. This resulted in lower coupon spreads, higher leverage attachment levels and easing credit terms throughout the leverage loan markets. We believe the 2024 cohort for new loan origination may eventually prove to be challenging for those who disproportionately ramped loans during the year. As we presented at our inaugural Investor Day, when you look at the dynamics of the 2024 cohort versus the previous decade, monthly net cash inflows were more than 2x their average levels and coupon spread levels for B, BB and BBB loans finished 2024 at 15% to 25% below historical average levels. We believe this dynamic may ultimately prove challenging for the total returns realized for the 2024 origination cohort. We continue to strategically focus on first lien investing at the top of the capital structure and prefer to utilize secured yield enhancement provisions such as PIK features, exit fees and MOICs to drive yields at the top of the capital structure rather than reaching deeper into capital structures for mezzanine and equity co-investments. We believe our continued investment selectivity and proportional deployment levels helped us to invest in first lien loans at higher spreads when compared to the overall loan markets during the quarter. The weighted average yield for our total funded first lien debt investments for the quarter based on our investment cost was the equivalent of SOFR plus 7% and approximately SOFR plus 6.1% for direct [indiscernible] investments in new companies. We also continued our highly selective focus on secondary investments where we see attractive risk return profiles or the opportunity to acquire lightly syndicated first-lien loan tranches at significant discounts to par. Our investments in the first lien term loans of Inotiv and Coinmac are representative of this strategy. This quarter, a significant increase in PIK income was primarily driven by our structured PIK term loan investment in Homer City Power. Given the significant redevelopment activities completed at Homer City, we have returned the loan to accrual status this quarter, which resulted in the recognition of past PIK interest that had not been previously accrued. As we discussed in previous quarters and more specifically detailed at our inaugural Investor Day, the majority of our annual PIK income is strategically derived from highly structured situations such as our investment in litigation finance portfolios where we can attain higher yields by matching flexible PIK timing features with strict cash flow sweeps upon collections or through coupon structures where PIK is incremental to our cash interest. Approximately 64% of our PIK investments are in portfolio companies risk-rated either 1 or 2 and 98% risk-rated 3 or better. As a result, we believe this PIK income may not compare to restructured PIK driven by deterioration in credit. Turning now to our Q4 investment and portfolio activity. Our Q4 investment activity consisted of approximately 60% of add-on investments for existing portfolio companies and 40% for new company investments. approximately 80% of total fundings were completed on a private direct versus a secondary market basis. We closed direct first lien financing for 2 new platforms, CrossLink Tax Solutions and Newbury Franklin Industrials. On the syndicated secondary side, we completed new first lien term loan investments in [ AKO ], Grain and Coinmac. We completed add-on investments for portfolio companies, including David's Bridal, HealthWay, Berlitz LP, Community Tree Service, Anthem, MOSS, Isagenix, [ Sleep OpCo ], Adapt laser, Inotiv, Hollander, Homer City and Juice Plus. During Q4, we made a total of $106 million in new investment commitments across 5 new and 15 existing portfolio companies of which $100 million was funded. Approximately 96% were first lien loans. We have also funded a total of $12 million of previously unfunded commitments. We had sales and repayments totaling $47.8 million for the quarter, which consisted of the full paydown of investment tranches in [indiscernible], MedPlast, GSE Technologies and Critical Nurse Staffing. We also completed an exchange of a portion of our first lien term loan in Playboy Enterprises into a convertible preferred investment in connection with the company's announcement of the strategic licensing and investment transaction with Byborg Enterprises. As a result of all of these activities, our net funded investments increased by approximately $64 million during the quarter. As Michael referenced, our net portfolio decline was driven by declines in the unrealized mark-to-market value of our equity investments, including David's Bridal, HealthWay, KNN, Carestream, ARC Financial, URS Topco and TriMark and our first lien term loan investment in Anthem Sports & Entertainment. As we mentioned on previous quarterly calls, we expect to see significant quarter-to-quarter volatility in the marks of David's Bridal equity due to the larger overall relative size of our investment as well as the highly seasonal nature of the company's operations and working capital profile. The mark-to-market decline in David's Bridal for the quarter was driven by the seasonal increase in debt as Q4 historically represents increased need for working capital to support merchandise inventory for the bridal season that traditionally kicks off in mid-January. In addition, we invested incremental capital to accelerate the company's recently announced growth-oriented strategic transformation of the business to an increasingly asset-light digitally and media-driven bridal marketplace business that expands the company's market power from the $4 billion wedding dress segment into the $65-plus billion wedding industry. The mark-to-market declines in HealthWay, KNN, ARC Financial, Anthem Sports and TriMark were driven primarily by delays in expected revenue pipeline that impacted trailing EBITDA performance. In terms of unrealized mark gains, we had marked increases in the unrealized value of investments, including Longview Power, Homer City Generation, [ CAC Medical ], Palmetto Solar and Berlitz LP based on stronger underlying performance trends. From a portfolio credit perspective, our nonaccruals decreased from 1.85% of fair value in Q3 to 1.41% in Q4. We added 2 new names to nonaccrual this quarter, our term loan investment in Sequoia Healthcare and a second lien investment in Securus Technologies. We also removed 1 name, our term loan investment in Homer City and returned to accrual status, as I previously mentioned. Sequoia is a subsidiary investment within CarePoint Health, which is currently being restructured in the bankruptcy process. Given the uncertainty of the process, we have elected to place Sequoia on nonaccrual. Securus is evaluating strategic alternatives, including a potential restructuring. Given the uncertainty, we have placed our second lien investment on nonaccrual until there is more clarity. On an absolute basis, nonaccruals continue to be largely in line with historical experience, and we are pleased with the continued credit performance of our portfolio, particularly in the current interest rate environment. Overall, our portfolio remains defensive in nature with 86% in first lien investments. Approximately 98% of our portfolio remains risk rated 3 or better. Our risk rated 3 investments which are investments where we expect full repayment but are either spending more engagement time and/or have seen increased risk since the initial asset purchase declined from approximately 11.8% in Q3 to 10.6% in Q4. I'll now turn the call over to Keith.